Overview

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Status:
RECRUITING
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
The study plans to learn more about what happens to the body after bariatric surgery in people 12 to 24 years old. The study aims to understand why people respond differently to bariatric surgery and how to define success beyond weight loss alone. The study also plans to learn more about whether a medication (semaglutide) can help people 12 to 24 years old who, between 1 and 2 years after bariatric surgery, have not lost as much weight as expected.
Phase:
PHASE1
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)